Growth and growth disorders in 2017

Genetic and epigenetic regulation of childhood growth

Studies of rare growth disorders taken together with large-scale genetic studies of adult height variability have uncovered a large genetic network regulating childhood growth. Advances in technology and experimental model systems will help decipher the molecular mechanisms of this complex network and lead to novel treatment approaches for growth disorders.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Allelic series in growth genes.


  1. 1

    Baron, J. et al. Short and tall stature: a new paradigm emerges. Nat. Rev. Endocrinol. 11, 735–746 (2015).

    CAS  Article  Google Scholar 

  2. 2

    Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014).

    CAS  Article  Google Scholar 

  3. 3

    MacLean, H. E. & Kronenberg, H. M. Expression of Stra13 during mouse endochondral bone development. Gene Expr. Patterns 4, 633–636 (2004).

    CAS  Article  Google Scholar 

  4. 4

    Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017).

    CAS  Article  Google Scholar 

  5. 5

    Tatton-Brown, K. et al. Mutations in epigenetic regulation genes are a major cause of overgrowth with intellectual disability. Am. J. Hum. Genet. 100, 725–736 (2017).

    CAS  Article  Google Scholar 

  6. 6

    Imagawa, E. et al. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome. Hum. Mutat. 38, 637–648 (2017).

    CAS  Article  Google Scholar 

  7. 7

    Lui, J. C. et al. Ezh2 mutations found in the Weaver overgrowth syndrome cause a partial loss of H3K27 histone methyltransferase activity. J. Clin. Endocrinol. Metab. (2017).

  8. 8

    Lui, J. C. et al. EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy. Nat. Commun. 7, 13685 (2016).

    CAS  Article  Google Scholar 

  9. 9

    Mirzamohammadi, F. et al. Polycomb repressive complex 2 regulates skeletal growth by suppressing Wnt and TGF-β signalling. Nat. Commun. 7, 12047 (2016).

    CAS  Article  Google Scholar 

  10. 10

    Montalbano, A. et al. Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency. EMBO Mol. Med. 8, 1455–1469 (2016).

    CAS  Article  Google Scholar 

Download references


The work of O.N. was supported by grants from the Swedish Research Council (project K2015-54X-22 736-01-4 and 2015-02227), the Swedish Governmental Agency for Innovation Systems (Vinnova) (2014-01438), the Marianne and Marcus Wallenberg Foundation, the Stockholm County Council, Byggmästare Olle Engkvist Stiftelse, the Swedish Society of Medicine, the Novo Nordisk Foundation (grant NNF16OC0021508), the Erik och Edith Fernström Foundation for Medical Research, HKH Kronprinsessan Lovisas förening för barnasjukvård, Sällskapet Barnavård, Stiftelsen Frimurare Barnhuset i Stockholm, Karolinska Institutet, Stockholm, Sweden and Örebro University, Örebro, Sweden.

Author information



Corresponding author

Correspondence to Ola Nilsson.

Ethics declarations

Competing interests

O.N. has received speakers' honoraria from Lilly, Merck Serono and Pfizer, and research support from the Novo Nordisk Foundation.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nilsson, O. Genetic and epigenetic regulation of childhood growth. Nat Rev Endocrinol 14, 70–72 (2018).

Download citation


Quick links

Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing